interferon beta-1a
interferon beta-1a is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including REBIF, AVONEX, Rebif. Available dosage forms: injection, solution, kit, liquid.
Drug Details
- Generic Name
- interferon beta-1a
- Brand Names
- REBIF, AVONEX, Rebif
- Application Number
- BLA103780
- Sponsor
- EMD Serono, Inc.
- NDC Codes
- 5
- Dosage Forms
- INJECTION, SOLUTION, KIT, LIQUID
- Routes
- SUBCUTANEOUS, INTRAMUSCULAR
- Active Ingredients
- INTERFERON BETA-1A
Indications and Usage
1 INDICATIONS AND USAGE REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Rebif is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )